Get 40% Off
💰 Warren Buffett reveals a $6.72 billion stake in ChubbCopy Portfolios

Raytheon's Shares Up On Merger Deal With United Technologies

Published 06/09/2019, 10:00 PM
Updated 07/09/2023, 06:31 AM
NOC
-
RTN
-
COL
-
RTX
-
AJRD
-

Raytheon Company (NYSE:RTN) recently inked an all-stock merger deal with multinational conglomerate United Technologies Corp (NYSE:UTX) . Considered to be the biggest merger in the U.S. aerospace and defense space, this deal will generate a conglomerate worth $121 billion (as per Reuters).

The combined company, to be named Raytheon Technologies Corporation, will have approximately $74 billion in pro forma 2019 sales. The deal, a tax-free one, is expected to close in the first half of 2020, following the completion of United Technologies’ earlier announced separation from its Otis and Carrier businesses.

Significance of the Deal

Per the terms of the latest agreement, Raytheon’s shareowners will receive 2.3348 shares in the combined company for each of this missile maker’s share. On completion of the merger, Raytheon’s shareowners will own approximately 43% of the combined company.

Following the completion of the deal, Raytheon’s shareholders can expect return of capital in the range of $18-$20 billion during the first three years. By the fourth year of the closure, the merger is projected to generate more than $1 billion of gross annual cost synergies.

Notably, the new company’s portfolio will comprise aerospace electronics, communications and other equipment from United Technologies along with Raytheon’s military aircraft and missile equipment. Post formation, Raytheon Technologies is certainly expected to acquire a significant position in the U.S. aerospace and defense space, by offering more cost-effective solutions backed by an expanded product portfolio.

Other Major Deals in the Same Space

Growing need for cost-reduction initiatives, intensifying competition and increased control over production procedures have lately prompted defense industry bigwigs to engage in frequent mergers and acquisitions. Moreover, the current U.S. administration has been increasing the defense budget over the past couple of years, which have all the more enticed defense biggies to strengthen their product portfolio through mergers. We believe these factors have also played a key role in Raytheon’s latest merger deal.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Regarding mergers, it is imperative to mention that last year we witnessed a handful of similar mega deals in the U.S. aerospace and defense space. In June 2018, Northrop Grumman (NYSE:NOC) completed the acquisition of Orbital ATK for $9.2 billion. Next, United Technologies completed the Rockwell Collins (NYSE:COL) buyout for $30 billion in November 2018 to emerge as one of the world’s largest aircraft-equipment manufacturers. Such consolidations by leading industry players should improve economies of scale for the aerospace-defense equipment industry as a whole.

Price Performance

Following the latest merger deal, shares of Raytheon have gained 1.3% in the pre-market trading session. This reflects that news of this acquisition has received positive response from the market.

Zacks Rank & Key Pick

Raytheon currently carries a Zacks Rank #3 (Hold). A better-ranked stock in the same industry is Aerojet Rocketdyne Holdings, Inc. (NYSE:AJRD) , which sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Aerojet Rocketdyne delivered average positive earnings surprise of 36.67% in the last four quarters. The Zacks Consensus Estimate for 2019 earnings has moved 18.4% up to $1.67 over the past 90 days.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Northrop Grumman Corporation (NOC): Free Stock Analysis Report

Aerojet Rocketdyne Holdings, Inc. (AJRD): Free Stock Analysis Report

United Technologies Corporation (UTX): Free Stock Analysis Report

Raytheon Company (RTN): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.